Innovation Driving Ireland's Transition From Medtech Supplier To Strategic Partner
Executive Summary
With cost-conscious medtech companies looking increasingly towards Asia and South America to set up their facilities, it may come as a surprise to some that Ireland remains one of the top medical device manufacturing hubs in the world, exporting around €12.6bn of medtech goods per year. It's not cost, though, that keeps Ireland competitive against these other countries but its innovation capabilities - in which the government has made significant and judicious investments since the early 2000s. Deirdre Glenn, Enterprise Ireland's Director of Lifesciences, spoke to Medtech Insight about how the country successfully grew its medtech sector to become a community of innovators and strategic medtech partners.
You may also be interested in...
Q&A: Ireland's Success In Attracting Medtech Companies
Medtech Insight talked to Rachel Shelly, the Head of Medical Technologies for IDA Ireland, about the Irish government's continuing efforts to attract medtech companies, the implications of Brexit, and the growing emphasis on data-analytics within the medtech industry in Ireland.
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.